Shanxi Zhendong pharmaceutical Co. LTD.   Report issue

For profit Phase 3 Phase 4
Founded: Changzhi China (1995)
Status: No NME R&D (1995)

Organization Overview

First Clinical Trial
2014
NCT04301466
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Shanxi Zhendong Pharmacy Co., Ltd

Active Ingredients

Drugs in Phase 4 Trials (2)

kushen (1 trial)

levofloxacin (levaquin) (1 trial)

Drugs in Phase 3 Trials (1)

qizhitongluo (1 trial)

Drugs in Other Trials (1)

kuh-seng (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cognitive Dysfunction (Phase 3)

Head and Neck Neoplasms (Phase 4)

Mucositis (Phase 4)

Stomatitis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4